Decker E-M, von Ohle C, Weiger R, Wiech I, Brecx M
Department of Conservative Dentistry, School of Dental Medicine, University of Tuebingen, Germany.
J Periodontal Res. 2005 Oct;40(5):373-7. doi: 10.1111/j.1600-0765.2005.00817.x.
The minor efficacy of chlorhexidine (CHX) on other cariogenic bacteria than mutans streptococci such as Streptococcus sanguinis may contribute to uneffective antiplaque strategies.
In addition to CHX (0.1%) as positive control and saline as negative control, two chitosan derivatives (0.2%) and their CHX combinations were applied to planktonic and attached sanguinis streptococci for 2 min. In a preclinical biofilm model, the bacteria suspended in human sterile saliva were allowed to attach to human enamel slides for 60 min under flow conditions mimicking human salivation. The efficacy of the test agents on streptococci was screened by the following parameters: vitality status, colony-forming units (CFU)/ml and cell density on enamel. The first combination reduced the bacterial vitality to approximately 0% and yielded a strong CFU reduction of 2-3 log(10) units, much stronger than CHX alone. Furthermore, the first chitosan derivative showed a significant decrease of the surface coverage with these treated streptococci after attachment to enamel.
Based on these results, a new CHX formulation would be beneficial unifying the bioadhesive properties of chitosan with the antibacterial activity of CHX synergistically resulting in a superior antiplaque effect than CHX alone.
洗必泰(CHX)对除变形链球菌外的其他致龋菌(如血链球菌)的疗效欠佳,这可能导致抗牙菌斑策略效果不佳。
除了使用0.1%的CHX作为阳性对照和生理盐水作为阴性对照外,还将两种壳聚糖衍生物(0.2%)及其与CHX的组合应用于浮游态和附着态的血链球菌,处理2分钟。在临床前生物膜模型中,将悬浮于人体无菌唾液中的细菌在模拟人体唾液流动的条件下,使其附着于人类牙釉质玻片60分钟。通过以下参数筛选受试药物对链球菌的疗效:活力状态、菌落形成单位(CFU)/毫升以及牙釉质上的细胞密度。第一种组合使细菌活力降至约0%,并使CFU大幅降低2 - 3个对数(10)单位,比单独使用CHX的效果要强得多。此外,第一种壳聚糖衍生物在这些经处理的链球菌附着于牙釉质后,表面覆盖率显著降低。
基于这些结果,一种新的CHX制剂将壳聚糖的生物粘附特性与CHX的抗菌活性协同结合,这将是有益的,从而产生比单独使用CHX更优异的抗牙菌斑效果。